Last Updated: November 13, 2026

Alkem Company Profile

« Back to Dashboard

What is the competitive landscape for ALKEM

ALKEM has one hundred and forty-seven approved drugs.

There are thirteen tentative approvals on ALKEM drugs.

Summary for Alkem

US Patents:	0
Tradenames:	119
Ingredients:	118
NDAs:	147
Patent Litigation for Alkem:	See patent lawsuits for Alkem

Drugs and US Patents for Alkem

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alkem Labs Ltd	MIRABEGRON	mirabegron	TABLET, EXTENDED RELEASE;ORAL	215948-002	Feb 12, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Alkem Labs Ltd	CEFDINIR	cefdinir	FOR SUSPENSION;ORAL	210534-001	Feb 19, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Alkem Labs Ltd	AMPHETAMINE SULFATE	amphetamine sulfate	TABLET;ORAL	213720-001	Oct 27, 2020	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
Alkem Labs Ltd	CEFPROZIL	cefprozil	TABLET;ORAL	090857-001	Apr 9, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Alkem

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alkem Labs Ltd	MARINOL	dronabinol	CAPSULE;ORAL	018651-001	May 31, 1985	6,703,418	⤷ Start Trial
Alkem Labs Ltd	MARINOL	dronabinol	CAPSULE;ORAL	018651-003	May 31, 1985	6,703,418	⤷ Start Trial
Alkem Labs Ltd	MARINOL	dronabinol	CAPSULE;ORAL	018651-002	May 31, 1985	6,703,418	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.